Home|2019|September

Karine Chevrie, PhD
Regulatory Affairs and Quality Director

Karine Chevrie, PhD

Regulatory Affairs and Quality Director
Karine Chevrie has a PhD in Biochemistry and 20 years’ experience in the field of medical devices. During her career, she was notably in charge of regulatory strategies which contributed to obtaining CE marks and FDA approvals. She also built and managed quality management systems complying to ISO 13485 and 21CFR820 US regulation. From 2006 to 2015, Karine Chevrie held the position of Regulatory Affairs and Quality Director at EOS Imaging. Previously, she was for 7 years in charge of medical devices that hold a biological risk at AFSSAPS (now ANSM). In that framework, she participated in several work groups at the European Commission.

2020-04-09T17:45:20+02:00September 9th, 2019|Management|

Lloyd Diamond
CEO

President and CEO

Lloyd Diamond, a US citizen, is a seasoned medtech executive and CEO with 25 years of disruptive technology commercialization experience in the life science industry. He most recently served as the CEO of Precise Light Surgical, a commercially ready medical device company in Silicon Valley. Prior to that, he was the CEO of Bonesupport AB, a European orthobiologic company, where he drove rapid market penetration in Europe and the US which led to a successful IPO on the NASDAQ OMX in Stockholm. Lloyd has first-hand experience in the ophthalmology segment as he was responsible for managing Lumenis’ global surgical and vision franchises. He has commercialized many other disruptive technology platforms including at Kyphon and Laserscope. Lloyd received a dual degree in Biochemistry and Marketing from Florida Atlantic University and an MBA from the Thunderbird School of Global Management at Arizona State University.

2020-06-12T14:22:10+02:00September 9th, 2019|Board of Directors, Management|

2019 KOL EVENT MEETING ON PROMISING RESULTS WITH PRIMA IN ADVANCED DRY-AGE-RELATED MACULAR DEGENERATION (AMD) – SHORT VERSION

Highlights of the KOL meeting : Three ophthalmology experts discuss PRIMA in advanced dry-AMD :

· Pr. F. Holz : “Real world unmet medical need : atrophic dry-AMD”

· Pr. D. Palanker : “PRIMA inventor’s motivation”

· Pr. J-A. Sahel : “First in human study PRIMA in AMD”

To have access to the Powerpoint presentation, please click on the title

 

2019-09-09T00:17:50+02:00September 3rd, 2019|Events|
Go to Top